SCHEMBL17386122

SCHEMBL17386122

COC(=O)c1ccc(OCCc2cc(C)cc(OC)c2)c(B2OC(C)(C)C(C)(C)O2)c1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ UCHL1 P09936 1/20 0.39
▸ KMT2A Q03164 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ LPAR1 Q92633 3/20 0.35
▸ TDP1 Q9NUW8 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ MAPT P10636 4/20 0.34
▸ LMNA P02545 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CXCR2 P25025 1/20 0.33
▸ TTR P02766 1/20 0.33
▸ MTNR1A P48039 1/20 0.33
▸ MTNR1B P49286 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17429672 0.93 UCHL1 (0.36) UCHL1KMT2AALDH1A1MEN1LPAR1
SCHEMBL17418052 0.83 UCHL1 (0.40) UCHL1KMT2AALDH1A1TDP1MAPT
SCHEMBL17386366 0.82 UCHL1 (0.36) UCHL1KMT2AALDH1A1TDP1L3MBTL1
SCHEMBL17429673 0.82 TDP1 (0.34) UCHL1ALDH1A1TDP1L3MBTL1MAPT
SCHEMBL23803972 0.80 NLRP3 (0.40) UCHL1MAPT
SCHEMBL17417969 0.80 UCHL1 (0.37) UCHL1ALDH1A1MAPTTSHR
SCHEMBL31092565 0.79 MAPT (0.39) UCHL1KMT2ATDP1L3MBTL1MAPT
SCHEMBL17386038 0.79 ALDH1A1 (0.41) KMT2AALDH1A1MEN1TDP1L3MBTL1
SCHEMBL5899519 0.77 MAPT (0.50) UCHL1KMT2AALDH1A1MEN1MAPT
SCHEMBL26926518 0.77 SMPD1 (0.47) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9643946-B2 Tricyclic compound and use thereof SK CHEMICALS CO., LTD. (KR) 2017-05-09 — — US disclosed
US-9643946-B2 Tricyclic compound and use thereof SK CHEMICALS CO., LTD. (KR) 2017-05-09 — — US disclosed
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF SK CHEMICALS CO., LTD. (KR) 2016-01-14 — — US disclosed
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF SK CHEMICALS CO., LTD. (KR) 2016-01-14 — — US disclosed
EP-2963027-A1 TRICYCLIC COMPOUND AND USE THEREOF SK Chemicals Co., Ltd. (KR) 2016-01-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF GPR65, GPR119, GPR35 UCHL1 4494/4885KMT2A 4155/4885ALDH1A1 2066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback